Pandemic influenza: is there a corporate duty to prepare?
- PMID: 19998573
Pandemic influenza: is there a corporate duty to prepare?
Abstract
This article considers whether in the wake of an influenza pandemic companies may be exposed to claims of legal liability for failing to provide employees with access to antiviral medications, as the Department of Health and Human Services (HHS) now encourages businesses to do. It begins by describing influenza and influenza pandemics. It then discusses the benefits and limitations of antiviral therapies and the recent creation of antiviral option programs. It concludes by considering whether claims may be brought on the theory that corporate leadership is under a duty to prepare for a pandemic by considering whether to provide access to antiviral protection for employees.
Similar articles
-
Influenza and the pandemic threat.Singapore Med J. 2006 Jun;47(6):463-70. Singapore Med J. 2006. PMID: 16752013 Review.
-
The pandemic threat: are we prepared?Issue Brief (Mass Health Policy Forum). 2006 Jun 8;(29):1-14. Issue Brief (Mass Health Policy Forum). 2006. PMID: 16886304
-
Pre- or post-pandemic influenza vaccine?Vaccine. 2007 Jun 28;25(27):4983-4. doi: 10.1016/j.vaccine.2007.05.033. Epub 2007 May 29. Vaccine. 2007. PMID: 17555851 No abstract available.
-
Pandemic flu vaccine: are we doing enough?Clin Pharmacol Ther. 2007 Dec;82(6):633-5. doi: 10.1038/sj.clpt.6100417. Clin Pharmacol Ther. 2007. PMID: 17998908
-
Neuraminidase inhibitors and their role in avian and pandemic influenza.Antivir Ther. 2007;12(4 Pt B):593-602. Antivir Ther. 2007. PMID: 17944267 Review.
MeSH terms
Substances
LinkOut - more resources
Medical